Pharmaceutical company payments to Japanese breast cancer practice guideline authors

Pharmaceutical company payments to Japanese breast cancer practice guideline authors

Abstract Background The creation of breast cancer practice guidelines requires proper management of financial relationships with drug companies, as they can introduce conflicts of interest (COIs) among guideline authors. However, little is known about the specific landscape and fraction of financial...

Full description

Bibliographic Details
Main Authors: Anju Murayama, Kenichi Higuchi, Keerthana R. Byreddy, Kugo Hinari, Yuki Senoo
Format: Article
Language:English
Published: Wiley 2024-06-01
Series:Clinical and Translational Discovery
Subjects:
clinical practice guideline
conflicts of interest
ethics
evidence‐based medicine
health policy
pharmaceutical companies
Online Access:https://doi.org/10.1002/ctd2.304

Internet

https://doi.org/10.1002/ctd2.304

Similar Items